Good morning and welcome to the AdvanSix Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would like now to turn the conference over to Adam Kressel, Vice President of Investor Relations and Treasurer. Please go ahead.

Thank you, Alan. Good morning and welcome to AdvanSix’s second quarter 2023 earnings conference call. With me here today are President and CEO, Erin Kane, and Senior Vice President and CFO, Michael Preston. This call and webcast, including any non-GAAP reconciliations are available on our website at investors.advansix.com. Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our business as we see it today. Those elements can change and the actual results could differ materially from those projected and we ask that you consider them in that light. We refer you to the forward-looking statements included in our press release and earnings presentation. In addition, we identify the principle risks and uncertainties that affect our performance in our SEC filings, including our annual report on Form 10-K as further updated in subsequent filings with the SEC. This morning, we will review our financial results for the second quarter of 2023 and share our outlook for our key product lines and end markets. Finally, we’ll leave time for your questions at the end. So, with that, I’ll turn the call over to AdvanSix’s President and CEO, Erin Kane.

Thanks, Adam, and good morning everyone. Thank you for joining us and for your continued interest in AdvanSix. As you saw in our press release, AdvanSix delivered solid earnings results and cash flow results in the second quarter amid a continued dynamic macro environment and against a record second quarter in the prior year period. The performance further illustrates the value and resilience of our diversified chemistry company. Our team executed on strong in season demand for plant nutrients, albeit in a lower nitrogen and raw material pricing environment. They navigated unfavorable nylon industry supply and demand conditions and an increased low priced imports while continuing to experience balanced North American acetone supply and demand dynamics in our chemical intermediate portfolio. Our long-term confidence is reflected in continued share repurchases through July as well as our announced 10% increase in our quarterly cash dividend for the third quarter. We continue to make meaningful progress on our sustainability initiatives and ESG performance. We will soon publish our annual sustainability report, which highlights the terrific work happening around the organization integrated with our overall strategic priorities, including the recent launch of our 100% post-consumer recycled nylon, which I'll speak to you later on this call. I encourage you all to take a read through it later this month. Looking ahead, our diverse end market exposure and integrated efficient and cost advantage business model provides resiliency, particularly in an evolving global macro environment. While we anticipate seasonality impacts within our Plant Nutrients business and demand weakness in certain market segments within our Nylon Solutions and Chemical Intermediates product lines, we remain confident in our demonstrated ability to execute and perform through various macroeconomic cycles. We are highly focused on what is in our control, including driving superior operational and commercial performance to meet the evolving needs of our customers, building capabilities to strengthen our innovation and portfolio resiliency and executing against a balanced and disciplined capital deployment framework. Our organization's collective efforts are centered around driving best possible outcomes for our business in the current set of industry conditions while supporting sustainable long-term shareholder value. Now let me turn the call over to Mike.

All right, thanks, Erin and good morning everyone. I'm now on Slide 4 where I'll provide a summary of the second quarter 2023 financial results. Overall, our results were solid considering the current environment and against a record prior year comparison. Sales of $428 million decreased approximately 27% in the quarter. Pricing was unfavorable by 25% overall. Market based pricing was unfavorable by 19%, primarily reflecting lower nutrient values, reducing ammonium sulfate pricing as well as lower nylon pricing. Raw material pass through pricing was also a headwind, down 6% following a net cost decrease in benzene and propylene. Volume declined approximately 2%, primarily driven by soft end market demand impacting portions of our nylon and chemical intermediates product lines. This was partially offset by higher domestic ammonium sulfate volume to meet in season customer demand compared to the prior year period, which was impacted by unfavorable weather conditions. Adjusted EBITDA was $66 million and I'll highlight the key year-over-year variances on the next slide. Adjusted earnings per share was $1.25, effective tax rate was 24.4% in the quarter, consistent with our full year expectation for an effective tax rate of approximately 24%. And finally, free cash flow was approximately $16 million in the quarter. Cash flow from operations of $35 million decreased roughly $61 million versus the prior year primarily due to lower net income and the unfavorable impact of changes in working capital, driven largely by the unwinding of ammonium sulfate pre-by cash advances this year versus prior year when there was no 2021 year end pre-buy. Capital expenditures of $19 million in the quarter increased $2 million versus the prior year. Let's turn to Slide 5. Here we highlight the key drivers of our second quarter Adjusted EBITDA performance year-over-year. Pricing of raw materials was roughly a $44 million headwind. Tracking our key variable margin drivers, ammonium sulfate on a net price over natural gas and sulfur basis was down year-over-year as significantly lower pricing was only partially offset by a reduction in input costs. Performance across our caprolactam and nylon portfolio over our key raws was also negative year-over-year, reflecting unfavorable supply and demand dynamics, pressuring global pricing in a lower raw material environment. And lastly, Chemical Intermediates price over raw spread increased year-over-year, largely reflecting acetone margin over falling propylene costs. Volume and sales mix were approximately $2 million favorable in the quarter, largely reflecting higher plant nutrient sales as previously discussed, partially offset by soft market conditions for our Nylon and Chemical Intermediate products tied to continued weak demand in building a construction and for consumer durables. We also saw an approximately $4 million favorable benefit from planned plant turnarounds year-over-year. Finally, all other items netted to a roughly $1 million unfavorable impact. Now let me turn the call back to Erin.

Thanks, Mike. I'm now on Slide 6 to discuss each of our product lines. Starting with Nylon Solutions, we've seen continued global pricing pressure on the back of unfavorable supply and demand industry conditions and increasing Chinese exports. The Asia caprolactam over benzene spreads averaged roughly $800 per ton in the second quarter of 2023, remaining roughly flat on a sequential basis, but down significantly year-over-year. The global composite price raw spreads, underperformed the Asia of spreads once again as a slower growth Chinese economy is leading to excess supply moving to other regions at lower prices. Trying to export started at an all-time high and we're seeing the most acute challenges through the engineered classic space. We're not only low priced nylon, but also competing material is coming into North America at an increasing rate. This comes at a time when demand overall has remained soft, leading to further margin compression. Across our other key end markets, building construction indicators have been mixed and we've yet to see a volume or price recovery in the fiber and filament space where we serve our carpet customers or in wire and cable which has exposure to residential applications. Lastly, Packaging, while a more resilient end use for our business has seen some demand softness tied to inflationary pressures impacting buying behavior and certain applications like bone and meat and protective packaging. Moving to Chemical Intermediates, industry realized acetone prices over refinery grade propylene costs continued to improve year-over-year in the second quarter. While Acetone demand downstream has seen some softness, particularly into the large buyer end applications, we see supply is generally balanced. This has been supported by stable acetone imports into the U.S. and persistent lower phenol global operating rates or reduced demand in epoxy resin, polycarbonate and nylon value…

Great. Thanks Erin. Alan, can you open the line for questions?

We will now begin the question and answer session. [Operator Instructions] Our first question comes from Vincent Anderson of Stifel. Please go ahead.

Yes. Good morning and nice job on the quarter.

Good morning.

Good morning. So purely hypothetically, how would a trade case against Nylon 6 from China compare to acetone or ammonium sulfate just given trade data doesn't disaggregate Nylon 6 from other nylon products? Is that something that's based on your prior experiences would be feasible?

Yes, certainly. Thanks for the question, Vincent. We want to keep all of our options open here and certainly ensuring fair trade practices is important to us as we continue to monitor the industry dynamics here. Our assessment is underway and as you pointed out, we've been in this position in the past in both our ammonium sulfate and [indiscernible] businesses and trade cases like these around the world. And we'll leverage our prior experience to participate in fair trade right if determined that that's the most appropriate action.

Okay, all right. And then can you just quickly remind us what types of agricultural products U.S. means going to and how did it perform this quarter given we've seen some pretty severe destocking and crop protection kind of everywhere else in the chemicals world?

Yes, no and our experience here would be the same. As a reminder, we go into the herbicides down the glyphosate chain with our MEPA product offerings and certainly on the AG chemical side their work and we did see more destocking that occurred based on the import levels that happened late last year. And so we have seen that on impact and certainly demand through what would have otherwise been a strong season like t we saw in dry fertilizer as -- basically down the chain and retailers and growers work through the higher inventory. But again, I think the underlying fundamentals generally it might support an opportunity set here as we come through into the next season.

Great. And if I could just ask a couple quick ones on the recycled content. So, if I remember correctly, your PIR nylon is tied with your own kind of internal manufacturing process waste for lack of a better term, but what is the feedstock for the post-consumer recycled nylon?

Yes. If you think about the opportunity set that we have with our customers and their value chain, we can take opportunity sets of monomers and back from them, they're in their streams as well. And so it's an expansion if you think about that envelope, opportunity set to be able to bring it back into our chain.

Okay, okay that makes sense. And then does Ogun [ph] already have food packaging products developed and ready to market with PCR nylon or is that your next step?

Certainly as we work with them in concert and create that opportunity set, so in Boba [ph] that's going to be in certain types of applications. Those are typically more mono oriented type packaging. The multi-film would work through our partners and in some of the other converters.

Got you. Okay, all right. Thank you very much.

You bet.

Thanks, Vincent.

Our next question comes from David Silver from CL King. Go ahead.

Okay, great. Good morning.

Good morning.

Yes, I have a few admittedly scattershot questions here. First question would have to do with your balance sheet and in particular inventories. So your second quarter ending inventory balances sharply higher than a year ago and I'm guessing the units difference is greater than the dollar difference just given the shifts in product pricing. So certainly some of that is related to your upcoming turnarounds or which may be underway now, but could you just maybe talk about your comfort level with the inventories as of June 30? And then in in particular, did the buildup of inventory have a meaningful impact on your reported results in the second quarter? In other words, did it improve your unit margins? Obviously you produce more than your shipping. Thank you.

Yes. No, I mean good question. So when you look at the inventory number as you point out we ended the quarter with $226 million of inventory and that was pretty flat relative to the first quarter Dave, about $1 million increase and up about $10 million since the end of the year. So again from a sequential basis not much of a change, but as you point out definitely a change from a year-over-year perspective and when you break that down, looking at roughly a $70 million increase in inventory from a year-over-year perspective. Raws were up in that $15 million range and we do have a lot of timing with respect to Q mean and based on the rotations and when we receive those. So that can certainly fluctuate from quarter-to-quarter. But the balance is really in the finished goods and the work in process. And as you point out, as we head into the turnaround, the plant turnaround here in the third quarter, we clearly like to head into those with higher inventory balances. So we don't disrupt sales and ensure continuity of sales to our customer base and so that's critically important to us And as we roll through the turnaround in the third quarter here and through the second half as we come out of that, we would expect there to be a reduction in inventory and that is what we are planning for here in the second half. And then as we've sort of pointed out, we have been faced with some soft demand conditions for nylon and certain intermediate products tied to building and construction as well as consumer durables that's also been a consideration. And we continue to sort of optimize and navigate as we progress here in the second half, but we are expecting a reduction in inventory as we head through the turnaround in the second half of the year.

Okay, great. Thank you for that. And I would like to ask you about your CapEx plans for this year. So no change in your targeted full year level, but I guess if you were just to divide that by four, the first half of the year you're kind of trailing, yes, the pace at which your full year CapEx spend would play out. Can you just maybe talk about how you get from here to there, in other words, with the turnaround and everything and a number of diverse initiatives included in that somewhat larger spend this year? Just to -- maybe just talk us through the back half of the year and how that spending might progress? Thank you.

Yes. Yes, no good question. In the first half, just to put some numbers around it, we -- our CapEx spend in the first half was roughly $44 million and we're still guiding to a 110 to 120 amount for the full year, which means that you know, the second half spend has to ramp up quite a bit about two thirds of the annual spend and roughly is in the second half. And as you know as we execute the turnaround a lot of the capital equipment that we've been planning for will be installed and our CapEx will increase as a result and so we do expect a ramp up here in the third quarter and then another ramp up in the 4th. And we talked about some of the projects that were focused on this year which is resulting in the increased and elevated spend. Some of those critical infrastructure projects that we've talked about, particularly some of the dock we have at our Frankfurt facility which we're performing some upgrades to and some other projects as well. So that is driving the spend for the year and what we expect here and in the second half Dave.

Okay. Thank you for that. One question to go back maybe to the nylon chain and the market dynamics right now and in particular China. You know, there's a lot of consensus on the fact that China is exporting a lot of nylon that they can't place domestically, nylon and its precursor. But I was just wondering, are they in your opinion, are there other nylon chain products that they are also you're seeing the same type of opportunistic export behavior perhaps out of China? And then I'm thinking of ammonium sulfate firstly, but anything else that you think is kind of filtering into the markets that we need to keep an eye on? Thank you.

Yes, sure. I can provide some context in the chain. You know, as you point out and mostly in our remarks, China export volumes globally, now sort of equate to three times the size of Chesterfield's capacity right. So the equivalent of three of our nylon plants are now being exported globally from China and certainly I just say that is in a slower growth environment for them. And certainly pressuring opportunity sets into Europe, but then also into North America. And the share predominantly coming in in the engineered plastics space and then that is also carrying downstream to where the plastic engineered compounds made of nylon 6 are also coming in, pressuring and competing with our customers. We extend that to sort of the broader chain obviously global flake caprolactam is being exported as well and then the result in the ammonium sulfate which we have seen for a number of years now and Chinese AS production exports effectively as they have expanded their capacity inland for [indiscernible] and that has brought ammonium sulfate. Ammonium sulfate has been flat in domestic consumption there. So it's effectively with every addition that they have added that ammonium sulfate is being exported globally and that has reached nearly 13 million tons if you think about it. So it's a significant consideration in the global marketplace. And that is predominantly and they are heading into Brazil, Southeast Asia. And so that's just a little bit of context in that regard, right. So I can certainly expand if there's anything more as a follow on, but that is what we're seeing in the value chain.

Yes. And as you answered earlier, I mean there tends to be a bit of a crazy quilt of trade restrictions and whatnot that go both ways, which kind of complicates this more, complicates the analysis, but no thank you for that. Erin, big picture question here. So I'll preface my remarks by saying I'm not a professional economist, but I've been a careful observer for a long time. And I would just again stipulate this is kind of two faced or a schizophrenic economy that industrial economy that we're in that I haven't really, I have a tough time finding a comparison just with the puts and takes as I look around. But in your opinion is the United States now in an industrial recession? In other words are the negatives broad enough that they're outweighing the positives that are out there? And if so, how does that change how you operate maybe tactically over the next few quarters?

Sure. Well I mean, as you point out there is data that underpins the backdrop of the macro environment that we are operating in. We are in the business of producing great chemistries and essential chemistries that are used on the value chain for consumer goods and essential products, right that impact millions around the world. But the reality is you've got S&P Global manufacturing PMI that is contracted for 11 months in a row. You have U.S. manufacturing PMI as of July that is contracted for nine straight months in a row. The evidence of destocking, reduction of global operating rates I think is certainly strong indication of the dynamic that you are suggesting. And as I pointed out we've been here before. This is a business that we have continued to focus on the core first principles and in environments like this, our cost advantage business model and efficiency comes into play. We are fortunate that we are able to run disproportionately higher utilization rates accordingly. So that supports our through cycle profitability and we continue as you know to focus on the areas of opportunity to expand the underlying earnings of this business through smart capital investments, through our bolt-ons on M&A. And our effectively our cost focus as well will need to come into play if this is to continue to be extended. But certainly this is not something that's just happening. This is a dynamic that has been progressing now for in some aspects of our business for the better part of the year.

Okay, great. I really appreciate your thoughts on that. Thank you.

Sure.

Thank you. This concludes our question-and-answer session. I would like now to turn the conference back over to Erin Kane for any closing remarks.

Thank you all again for your time and interest this morning. Despite the dynamic set of industry conditions and a record comparison in the prior year, we are proud that we delivered solid earnings and cash flow results in the second quarter of 2023. Our results once again demonstrated the strength of our business model and our position as a diversified chemistry company. While there are puts and takes across our end markets and broader macro uncertainty, we are focused on executing what is in our control, including our rigorous commitment to operational excellence, continuous enhancement of our long-term growth capabilities and making smart and disciplined capital deployment decisions to drive higher returns. With that, we look forward to speaking with you again next quarter. Stay safe and be well.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.